comparemela.com

Latest Breaking News On - Medicine trading down - Page 2 : comparemela.com

Morgan Stanley Trims Disc Medicine (NASDAQ:IRON) Target Price to $40 00

Disc Medicine (NASDAQ:IRON – Get Free Report) had its price objective cut by Morgan Stanley from $75.00 to $40.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has an “equal weight” rating on the stock. Morgan Stanley’s target price suggests a potential upside of 26.78% from the stock’s previous close. A […]

Editas Medicine, Inc (NASDAQ:EDIT) Receives $15 00 Consensus PT from Analysts

Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month price target […]

Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright

Disc Medicine (NASDAQ:IRON) Earns Buy Rating from HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Disc Medicine (NASDAQ:IRON) Rating Reiterated by Wedbush

Disc Medicine (NASDAQ:IRON) Rating Reiterated by Wedbush
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Editas Medicine (NASDAQ:EDIT) Stock Price Down 8 9%

Editas Medicine (NASDAQ:EDIT) Stock Price Down 8 9%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.